A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy

Emery, P, Vencovskỳ, J, Sylwestrzak, A et al. (10 more authors) (2017) A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Diseases, 76 (1). pp. 51-57. ISSN 0003-4967

Abstract

Metadata

Authors/Creators:
  • Emery, P
  • Vencovskỳ, J
  • Sylwestrzak, A
  • Leszczynski, P
  • Porawska, W
  • Baranauskaite, A
  • Tseluyko, V
  • Zhdan, VM
  • Stasiuk, B
  • Milasiene, R
  • Rodriguez, AAB
  • Cheong, SY
  • Ghil, J
Copyright, Publisher and Additional Information: © 2015, Author(s). This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Dates:
  • Published: January 2017
  • Accepted: 6 June 2015
  • Published (online): 6 July 2015
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 28 Jan 2016 12:41
Last Modified: 12 Feb 2019 12:58
Published Version: https://doi.org/10.1136/annrheumdis-2015-207588
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/annrheumdis-2015-207588

Share / Export

Statistics